Cargando…
HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey
SIMPLE SUMMARY: Treatment with intraperitoneal hyperthermic chemotherapy (HIPEC) has been criticized in ovarian cancer due to the lack of prospective and randomized clinical trials demonstrating its efficacy in improving outcomes. However, the publication of the Dutch clinical trial five years ago h...
Autores principales: | González Gil, Alida, Cerezuela Fernández-de Palencia, Álvaro, Gómez Ruiz, Álvaro Jesús, Gil Gómez, Elena, López Hernández, Francisco, Nieto Ruiz, Aníbal, Martínez, Jerónimo, Marhuenda, Iván, Cascales Campos, Pedro Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340748/ https://www.ncbi.nlm.nih.gov/pubmed/37444591 http://dx.doi.org/10.3390/cancers15133481 |
Ejemplares similares
-
Surgery and HIPEC in relapse for all patients with ovarian cancer?
por: Hasson, S.P., et al.
Publicado: (2023) -
Analysis of Spanish Parents’ Knowledge about ASD and Their Attitudes towards Inclusive Education
por: Gómez-Marí, Irene, et al.
Publicado: (2022) -
Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC
por: Peña-Arriaga, Magaly Denise, et al.
Publicado: (2023) -
DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC
por: Flasarova, Dominika, et al.
Publicado: (2023) -
Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
por: Manzanedo, Israel, et al.
Publicado: (2023)